Company AtriCure, Inc.

Equities

ATRC

US04963C2098

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for AtriCure, Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
22.61 ^USD	-1.91%		-3.33%	-36.65%

Apr. 23	Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32	MT
Apr. 18	AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management	CI

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Number of employees: 1,200

USD in Million	2022	Weight	2023	Weight	Delta
Appendage Management 40.1 %	132	40.1 %	160	40.1 %	+20.88%
Open Ablation 34.3 %	113	34.2 %	137	34.3 %	+21.11%
Minimally Invasive Ablation 12.8 %	45	13.5 %	51	12.8 %	+15.06%
Pain Management 12.8 %	41	12.3 %	51	12.8 %	+26.35%

USD in Million	2022	Weight	2023	Weight	Delta
United States 83.5 %	277	83.9 %	334	83.5 %	+20.33%
Europe 9.6 %	30	9.2 %	38	9.6 %	+26.43%
Asia/Pacific 6.1 %	21	6.3 %	25	6.1 %	+18.29%
Other International 0.7 %	2	0.6 %	3	0.7 %	+34.23%

Managers	Title	Age	Since
Michael Carrel CEO	Chief Executive Officer	53	12-11-01
Angela Wirick DFI	Director of Finance/CFO	46	14-06-30
Vinayak Doraiswamy CTO	Chief Tech/Sci/R&D Officer	52	17-02-28
Karl Dahlquist CMP	Compliance Officer	54	13-07-31
Salvatore Privitera CTO	Chief Tech/Sci/R&D Officer	57	17-07-17
Douglas Seith COO	Chief Operating Officer	58	03-12-31
Justin Noznesky SAM	Sales & Marketing	46	13-12-31
Deborah Yount HRO	Human Resources Officer	58	22-05-31

Members of the board	Title	Age	Since
Karen Prange BRD	Director/Board Member	60	19-12-03
Michael Carrel CEO	Chief Executive Officer	53	12-11-01
Sven Wehrwein BRD	Director/Board Member	73	16-11-09
B. Johnson CHM	Chairman	72	17-03-20
Robert White BRD	Director/Board Member	62	13-03-10
Shlomi Nachman BRD	Director/Board Member	-	Jan. 02
Maggie Yuen BRD	Director/Board Member	52	21-06-14
Regina Groves BRD	Director/Board Member	66	17-03-20
Deborah Telman BRD	Director/Board Member	59	21-06-14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	48,374,624	46,885,710 ( 96.92 %)	0	96.92 %

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.852 %	4,766,029	9.852 %	145 M $
BlackRock Advisors LLC 7.955 %	3,848,352	7.955 %	117 M $
AllianceBernstein LP 7.016 %	3,394,036	7.016 %	103 M $
Champlain Investment Partners LLC 4.352 %	2,105,395	4.352 %	64 M $
Macquarie Investment Management Business Trust 2.997 %	1,449,726	2.997 %	44 M $
First Light Asset Management LLC 2.790 %	1,349,443	2.790 %	41 M $
Wellington Management Co. LLP 2.748 %	1,329,457	2.748 %	40 M $
STATE STREET CORPORATION 2.490 %	1,204,415	2.490 %	37 M $
Invesco Advisers, Inc. 2.402 %	1,162,050	2.402 %	35 M $
Fred Alger Management LLC (13f Subfiler) 2.386 %	1,154,058	2.386 %	35 M $

AtriCure, Inc.

7555 Innovation Way

45040, Mason

http://www.atricure.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

22.61 USD

Average target price

51.89 USD

Spread / Average Target

+129.50%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ATRICURE, INC.	-36.65%	1.12B
ABBOTT LABORATORIES	-2.92%	185B
MEDTRONIC PLC	-3.80%	107B
BECTON, DICKINSON AND COMPANY	-5.48%	67.55B
DEXCOM, INC.	+11.22%	54.6B
CENCORA, INC.	+16.74%	47.42B
HOYA CORPORATION	+2.24%	42.24B
WEST PHARMACEUTICAL SERVICES, INC.	+4.56%	28.24B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.64%	26.42B
TERUMO CORPORATION	+11.47%	25.66B

Other Medical Equipment, Supplies & Distribution